Angiotensin II involvement in the development and persistence of amphetamine-induced sensitization: Striatal dopamine reuptake implications
Impact Factor: 2023 (2024 update): 2.7
Guardado en:
| Autores principales: | Basmadjian, Osvaldo M., Occhieppo, Victoria B., Montemerlo, Antonella E., Rivas, Gustavo A., Rubianes, María D., Baiardi, Gustavo, Bregonzio, Claudia |
|---|---|
| Otros Autores: | https://orcid.org/0000-0003-2354-6164 |
| Formato: | publishedVersion article |
| Lenguaje: | Inglés |
| Publicado: |
Federation of European Neuroscience Societies
2024
|
| Materias: | |
| Acceso en línea: | http://hdl.handle.net/11086/552953 https://rdu.unc.edu.ar/handle/11086/18306 https://onlinelibrary.wiley.com/doi/abs/10.1111/ejn.16312 https://pubmed.ncbi.nlm.nih.gov/38480476/ https://doi.org/10.1111/ejn.16312 |
| Aporte de: |
Ejemplares similares
-
The dopamine D 2 , but not D 3 or D 4 , receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice
por: Ralph, R.J., et al. -
The dopamine D 2 , but not D 3 or D 4 , receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice
Publicado: (1999) -
Drug Abuse and the RAS
por: Urbano, F.J., et al. -
Drug Abuse and the RAS
Publicado: (2015) -
Neuronal KIF5b deletion induces striatum-dependent locomotor impairments and defects in membrane presentation of dopamine D2 receptors
por: Cromberg, L.E., et al.